D C Tormey, P Bergevin, J Blom, W Petty. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Adenocarcinoma/drug therapyAdenocarcinoma, Bronchiolo-Alveolar/drug therapyAdrenal Gland Neoplasms/drug therapyAdultBleomycin/adverse effectsBleomycin/therapeutic useBlood PlateletsCarcinoma, Hepatocellular/drug therapyCarcinoma, Squamous Cell/drug therapyCarcinoma, Transitional Cell/drug therapyClinical Trials as TopicDoxorubicin/adverse effectsDoxorubicin/therapeutic useDrug Therapy, CombinationHumansLeukocyte CountLiver Neoplasms/drug therapyLung Neoplasms/drug therapyNeoplasm MetastasisNeoplasms/bloodNeoplasms/drug therapyUrinary Bladder Neoplasms/drug therapy
Substances： See more » BleomycinDoxorubicin
Year: 1973 PMID： 4128422
Source DB: PubMed Journal: Cancer Chemother Rep ISSN： 0069-0112